SLC5A2 and heart failure: In terms of treatment options, it may suggest that the SGLT2 group of drugs could be useful, as the trials have suggested reductions in heart failure and hospital admissions related to heart failure, although further studies to test these therapies in older populations are still needed (29, 30).